SQZ Biotechnologies Co (SQZ)

Sector:
HEALTH CARE
Industry:
BIOTECHNOLOGY & LIFE SCIENCES
SIC:
BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
CEO:
Howard Bernstein
Employees:
120
200 ARSENAL YARDS BLVD., STE. 210, WATERTOWN, MA 02472
617-898-8824

SQZ Biotechnologies develops cell therapies for patients with cancer, autoimmune, infectious diseases, and other serious conditions. Its lead product candidate is SQZ-PBMC-HPV, from its SQZ Antigen Presenting Cells platform, which is in a Phase I clinical trial as a monotherapy and in combination with other immuno-oncology agents. The company was incorporated in 2013 and is headquartered in Watertown, Massachusetts.

Data derived from most recent annual or quarterly report
Market Cap 16.869 Million Shares Outstanding29.491 Million Avg 30-day Volume 24.083 Thousand
P/E Ratio0.0 Dividend Yield0.0 EPS-2.61
Price to Revenue0.8875 Debt to Equity0.0 EBITDA-65.842 Million
Price to Book Value0.4113 Operating Margin-418.53939999999994 Enterprise Value-23.357 Million
Current Ratio3.503 EPS Growth0.015 Quick Ratio3.142
1 Yr BETA 0.9349 52-week High/Low 3.98 / 0.53 Profit Margin-409.0118
Operating Cash Flow Growth-5.9766 Altman Z-Score-8.0357 Free Cash Flow to Firm -73.127 Million
Earnings Report2023-08-09
View SEC Filings from SQZ instead.

View recent insider trading info

SQZ Biotechnologies Co YCharts
Yahoo! Finance finviz
SEC Web Site SEC DEF 14A Filings

Funds Holding SQZ (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
Click for Additional Filters
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding SQZ

Download CSV

Active Schedule 13D and 13G filings

Please sign in first

Recent Filings

Financial Reporting

Ownership

  • 4: filed on 2023-01-26 by CAPASSO RICHARD
  • 4: filed on 2023-01-26 by WARREN MARSHELLE SMITH
  • 4: filed on 2023-01-26 by KNOPF LAWRENCE J
  • 4: filed on 2023-01-26 by FIRST DAVID
  • 4: filed on 2023-01-26 by BERNSTEIN HOWARD PHD MD
  • 4: filed on 2022-08-16 by CAPASSO RICHARD
  • 4: filed on 2022-07-13 by ZAJIC MICAH
  • 4: filed on 2022-07-05 by SHAREI ARMON
  • 4: filed on 2022-07-05 by KNOPF LAWRENCE J
  • 4: filed on 2022-07-05 by CAPASSO RICHARD

    • Events (8k)

  • 8-K: filed on 2023-04-10:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
  • 8-K: filed on 2023-01-18:
    Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
    Item 7.01: Regulation FD Disclosure
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-12-06:
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-11-30:
    Item 2.05: Cost Associated with Exit or Disposal Activities
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 7.01: Regulation FD Disclosure
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-09-06:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 7.01: Regulation FD Disclosure
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-07-11:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 7.01: Regulation FD Disclosure
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-06-16:
    Item 5.07: Submission of Matters to a Vote of Security Holders
  • 8-K: filed on 2022-05-31:
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-05-19:
    Item 7.01: Regulation FD Disclosure
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-01-24:
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits

    • Proposed Sales (Form 144)

    Proxy

    Prospectus

    All

    Open Market Buys/Sells Last 60 Days

    Open Market Buys (P)

    none

    Open Market Sells (S)

    none

    Exercise Derivative Conversion (M)

    none

    Current/Former Insiders

    Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

    BERNSTEIN HOWARD PHD MD INTERIM CHIEF EXECUTIVE OFFICE

    • Officer
    • Director
    		 830,000 2023-01-24 1

    KNOPF LAWRENCE J GENERAL COUNSEL

    • Officer
    		 227,000 2023-01-24 2

    FIRST DAVID CHIEF PEOPLE OFFICER

    • Officer
    		 200,000 2023-01-24 1

    CAPASSO RICHARD SEE REMARKS

    • Officer
    		 213,000 2023-01-24 3

    WARREN MARSHELLE SMITH CHIEF MEDICAL OFFICER

    • Officer
    		 261,000 2023-01-24 1

    ZAJIC MICAH CHIEF FINANCIAL OFFICER

    • Officer
    		 10,000 2022-07-11 1

    SHAREI ARMON PRESIDENT AND CEO

    • Officer
    • Director
    		 287,884 2022-06-30 1

    SCHULMAN AMY W

    • Director
    • 10% Owner
    		 20,000 2022-06-15 1

    VINK PATRICK V.J.J.

    • Director
    		 20,000 2022-06-15 1

    SRIVASTAVA SAPNA

    • Director
    		 20,000 2022-06-15 1

    BOLNO PAUL

    • Director
    		 20,000 2022-06-15 1

    SCHEGERIN MARC

    • Director
    		 20,000 2022-06-15 1

    COULIE BERNARD

    • Director
    		 20,000 2022-06-15 1

    GARG PUSHKAL

    • Director
    		 20,000 2022-06-15 1

    JENSEN KLAVS F.

    • Director
    		 20,000 2022-06-15 1

    ELIA MARC

    • Director
    		 20,000 2022-06-15 1

    ROSEN OLIVER CHIEF MEDICAL OFFICER

    • Officer
    		 75,625 2021-02-23 0

    LOXAM TERI CHIEF FINANCIAL OFFICER

    • Officer
    		 75,950 2021-02-23 0

    AMERICAN INTERNATIONAL GROUP INC

    • 10% Owner
    		 No longer subject to file 2020-11-03 0

    TEMASEK HOLDINGS (PRIVATE) LTD

    • 10% Owner
    		 2,513,924 2020-11-03 0

    INVUS PUBLIC EQUITIES, L.P.

    MINNE PASCAL

    ARTAL INTERNATIONAL S.C.A.

    ARTAL INTERNATIONAL MANAGEMENT S.A.

    ARTAL GROUP S.A.

    WESTEND S.A.

    STICHTING ADMINISTRATIEKANTOOR WESTEND

    ARTAL TREASURY LTD

    INVUS PUBLIC EQUITIES ADVISORS, LLC

    • 10% Owner
    		 No longer subject to file 2020-11-03 0

    POLARIS MANAGEMENT CO. VII, L.L.C.

    POLARIS ENTREPRENEURS' FUND VII, L.P.

    POLARIS PARTNERS VII, L.P.

    • 10% Owner
    		 5,205,292 2020-11-03 0

    AMY SCHULMAN, AS TRUSTEE THE ARMON R. SHAREI IRREVOCABLE GST TRUST OF 2016, U/D/T DATED DECEMBER 29, 2016

    • 10% Owner
    		 No longer subject to file 2020-11-03 0

    LANGER ROBERT

    • 10% Owner
    		 243,987 2020-10-29 0

    MOESSLINGER ERIC

    • Director
    		 0 2020-10-29 0

    Insider Transactions Last 60 Days

    Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
    Disposed    		 Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
    No current insider transactions

    * -

    Transaction Code Definitions
    Code Definition
    A Grant, award or other acquisition pursuant to Rule 16b-3(d)
    C Conversion of derivative security
    D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
    E Expiration of short derivative position
    F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
    G Bona fide gift
    H Expiration (or cancellation) of long derivative position with value received
    I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
    J Other acquisition or disposition
    L Small acquisition under Rule 16a-6
    M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
    O Exercise of out-of-the-money derivative security
    P Open market or private purchase of non-derivative or derivative security
    S Open market or private sale of non-derivative or derivative security
    U Disposition pursuant to a tender of shares in a change of control transaction
    W Acquisition or disposition by will or the laws of descent and distribution
    X Exercise of in-the-money or at-the-money derivative security
    Z Deposit into or withdrawal from voting trust

    IBR Securities Loan Availability

    Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

    Security Date/Time Rebate Rate Fee Rate Shares Available
    SQZ BIOTECHNOLOGIES CO SQZ 2023-06-01 22:15:04 UTC 2.2251 2.8449 45000
    SQZ BIOTECHNOLOGIES CO SQZ 2023-06-01 21:45:04 UTC 2.2251 2.8449 45000
    SQZ BIOTECHNOLOGIES CO SQZ 2023-06-01 21:15:05 UTC 2.2251 2.8449 45000
    SQZ BIOTECHNOLOGIES CO SQZ 2023-06-01 20:45:03 UTC 2.2251 2.8449 45000
    SQZ BIOTECHNOLOGIES CO SQZ 2023-06-01 20:15:04 UTC 2.2251 2.8449 45000
    SQZ BIOTECHNOLOGIES CO SQZ 2023-06-01 19:45:03 UTC 2.2251 2.8449 45000
    SQZ BIOTECHNOLOGIES CO SQZ 2023-06-01 19:15:04 UTC 2.2251 2.8449 45000
    SQZ BIOTECHNOLOGIES CO SQZ 2023-06-01 18:45:03 UTC 2.2251 2.8449 45000
    SQZ BIOTECHNOLOGIES CO SQZ 2023-06-01 18:15:04 UTC 2.2251 2.8449 45000
    SQZ BIOTECHNOLOGIES CO SQZ 2023-06-01 17:45:04 UTC 2.2251 2.8449 45000
    SQZ BIOTECHNOLOGIES CO SQZ 2023-06-01 17:15:04 UTC 2.2251 2.8449 45000
    SQZ BIOTECHNOLOGIES CO SQZ 2023-06-01 16:45:04 UTC 2.2259 2.8341 45000
    SQZ BIOTECHNOLOGIES CO SQZ 2023-06-01 16:15:04 UTC 2.2259 2.8341 45000
    SQZ BIOTECHNOLOGIES CO SQZ 2023-06-01 15:45:03 UTC 2.2259 2.8341 45000
    SQZ BIOTECHNOLOGIES CO SQZ 2023-06-01 15:15:04 UTC 2.2259 2.8341 45000
    SQZ BIOTECHNOLOGIES CO SQZ 2023-06-01 14:45:04 UTC 2.2259 2.8341 45000
    SQZ BIOTECHNOLOGIES CO SQZ 2023-06-01 14:15:04 UTC 2.2259 2.8341 45000
    SQZ BIOTECHNOLOGIES CO SQZ 2023-06-01 13:45:04 UTC 2.2137 2.8463 45000
    SQZ BIOTECHNOLOGIES CO SQZ 2023-06-01 13:15:04 UTC 2.2137 2.8463 45000
    SQZ BIOTECHNOLOGIES CO SQZ 2023-06-01 12:45:04 UTC 2.2137 2.8463 50000

    Current Active Short Positions

    Holder Issuer Net Short Position Position Date Origin
    Weiss Strategic Interval Fund- Weiss Strategic Interval Fund SQZ -2247.0 shares, $-5123.16 2022-09-30 N-PORT
    Series Portfolios Trust- Weiss Alternative Multi-Strategy Fund SQZ -216.0 shares, $-177.12 2023-01-31 N-PORT

    No recent transactions

    *** To see all congressional transactions (since 2022) for this stock, please use the congressional transaction search page***

    Elevate your investments